Seven Bridge Financial Group, LLC Moderna, Inc. Transaction History

Seven Bridge Financial Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$117.13 - $176.59 $892,647 - $1.35 Million	-7,621 Closed	0 $0
Q1 2022 Apr 15, 2022	BUY	$126.46 - $235.05 $781,016 - $1.45 Million	6,176 Added 427.4%	7,621 $1.31 Million
Q4 2021 Jan 20, 2022	BUY	$225.82 - $368.51 $326,309 - $532,496	1,445 New	1,445 $367,000
Q4 2021 Jan 20, 2022	SELL	$225.82 - $368.51 $669,330 - $1.09 Million	-2,964 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$221.9 - $484.47 $8,432 - $18,409	-38 Reduced 1.27%	2,964 $1.14 Million
Q2 2021 Jul 26, 2021	BUY	$129.91 - $234.98 $178,626 - $323,097	1,375 Added 84.51%	3,002 $705,000
Q1 2021 Apr 20, 2021	BUY	$109.18 - $185.98 $177,635 - $302,589	1,627 New	1,627 $213,000
Q3 2019 Oct 09, 2019	SELL	$12.26 - $18.07 $6,130 - $9,035	-500 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$14.45 - $23.7 $11,198 - $18,367	-775 Reduced 60.78%	500 $10,000
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $17,238 - $23,970	1,275 New	1,275 $19,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.